Researchers make immunotherapy work for treatment-resistant lymphoma

Researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin’s lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically increased the success of the drugs in melanoma and lung cancer.

Share this post:


 

Related Posts